H.R. 3794 · 118th Congress (2023–2025)
FLASH Act of 2023
This bill expands federal contracting and other authorities to support the development and acquisition of products and supplies that are necessary for national public health and health security.
Specifically, the Department of Health and Human Services (HHS) may use noncompetitive procedures to procure medical countermeasures (e.g., vaccines), chemical materials and reagents, manufacturing supplies, and similar items that are needed to develop products for national public health and health security.
Additionally, HHS may acquire, subject to dollar limits and other conditions, innovative commercial products and services by soliciting proposals and selecting proposals through peer review.
Further, the bill expands the activities of the Biomedical Advanced Research and Development Authority (BARDA) to include supporting the design and development of prototypes for products to diagnose, mitigate, prevent, treat, or otherwise respond to biological, chemical, radiological, or nuclear threats, including pandemics or epidemics. If BARDA enters an initial transaction to design or develop such a test or prototype using competitive procedures, BARDA may use noncompetitive procedures for a follow-on transaction to produce the test or prototype.
!--tinycomments|2.1|data:application/json;base64,eyJtY2UtY29udmVyc2F0aW9uXzY5MDE5NjU1NjIxNzI0Njk4MDEwODM0Ijp7InVpZCI6Im1jZS1jb252ZXJzYXRpb25fNjkwMTk2NTU2MjE3MjQ2OTgwMTA4MzQiLCJjb21tZW50cyI6W3sidWlkIjoibWNlLWNvbnZlcnNhdGlvbl82OTAxOTY1NTYyMTcyNDY5ODAxMDgzNCIsImF1dGhvciI6InNmcmFuY2lzQGxpYi5sb2MuZ292IiwiYXV0aG9yTmFtZSI6InNmcmFuY2lzQGxpYi5sb2MuZ292IiwiY29udGVudCI6InRlc3RzIGFyZSBhbHJlYWR5IGluIGNvZGUiLCJjcmVhdGVkQXQiOiIyMDI0LTA4LTI2VDE4OjQ2OjUwLjgzNFoiLCJtb2RpZmllZEF0IjoiMjAyNC0wOC0yNlQxODo0Njo1MC44MzRaIn1dfX0=-->Show official title
To amend the Public Health Service Act to authorize the Biomedical Advanced Research and Development Authority to award follow-on production contracts or transactions, procure supplies for experimental or test purposes, and acquire innovative commercial products and commercial services, and for other purposes.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 3794’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Robert Garcia (D-CA-42)
- Policy area
- Health
- Subjects
- Advanced technology and technological innovations
- Congressional oversight
- Emergency planning and evacuation
- Health technology, devices, supplies
- Infectious and parasitic diseases
- Public contracts and procurement
- Research administration and funding
- Research and development
1 more
- Technology transfer and commercialization
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jun 5, 2023 – Jun 9, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Jun 13, 2023 · Hearing
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
FLASH Act of 2023
Display title, Short title · Introduced in House
Fast-track Logistics for Acquiring Supplies in a Hurry Act of 2023
Short title · Introduced in House
To amend the Public Health Service Act to authorize the Biomedical Advanced Research and Development Authority to award follow-on production contracts or transactions, procure supplies for experimental or test purposes, and acquire innovative commercial products and commercial services, and for other purposes.
Official title · Introduced in House